UroLift for Enlarged Prostate
UroLift, also called prostatic urethral lift (PUL), is a minimally invasive treatment for urinary symptoms caused by benign prostate enlargement. Small permanent implants are placed through a telescope in the urethra to pull the side lobes of the prostate away from the urinary channel. It does not cut out prostate tissue and usually allows a rapid return to routine activity. Its main advantage is a low risk of new ejaculatory or erectile problems. The trade-off is that symptom and flow improvement are generally less powerful and retreatment is more common than after tissue-removing operations such as TURP or HoLEP.
What is UroLift?
UroLift mechanically opens the prostatic urethra. Each implant has components that compress the enlarged lateral prostate tissue and maintain a wider channel. Unlike Rezūm, there is no period of tissue destruction and resorption, so improvement can begin relatively quickly.
The implants remain in place. Their number depends on prostate shape and the length of the obstructed channel.
Who may be suitable?
The procedure should be chosen after confirming that the symptoms are genuinely related to benign prostate obstruction rather than infection, urethral narrowing, bladder disease or a weak bladder alone.
- Bothersome lower urinary tract symptoms despite lifestyle measures or medicines.
- A moderately enlarged prostate with anatomy suitable for a prostatic urethral lift.
- Men who strongly value preservation of antegrade ejaculation.
- Patients who prefer a day-care or short procedure and accept a greater chance of needing another treatment later.
- Men without another untreated cause of obstruction such as urethral stricture.
When may another treatment be better?
- A very large prostate, where symptom relief may be less predictable.
- An obstructing middle/median lobe requires careful selection. Although median-lobe techniques and device indications exist, the 2026 EAU recommendation remains focused on prostates under 70 mL without an obstructing middle lobe.
- Repeated retention, bladder stones, upper-tract dilatation or severe obstruction where stronger de-obstruction is the priority.
- A patient who wants maximum flow improvement and long-term durability and is willing to accept a more invasive operation.
- Known allergy or anatomical circumstances that make implant placement inappropriate.
How is the procedure done?
A cystoscope is passed through the urethra and the obstructing lobes are inspected. The delivery device places implants from inside the urethra so that the tissue is retracted laterally. No external incision is made and no prostate tissue is removed.
The final opening is checked endoscopically. Because the mechanism is mechanical, there is no waiting for prostate tissue to shrink.
Anaesthesia and hospital stay
UroLift can be performed with local anaesthesia plus sedation, regional anaesthesia or a brief general anaesthetic depending on patient comfort and centre practice. It is commonly performed as a day-care procedure.
Will I need a catheter?
Many patients can pass urine without a catheter after UroLift, but catheterisation may still be needed if there is significant swelling, pre-existing retention or difficulty voiding after the procedure.
Potential benefits
- Rapid recovery compared with resection.
- No tissue removal and usually little bleeding.
- Low risk of new erectile dysfunction.
- Antegrade ejaculation is usually preserved.
Important limitations
- Less improvement in flow and symptoms than TURP in comparative studies.
- Permanent implants remain in the prostate.
- Higher chance of later reintervention than TURP or laser vaporisation.
- Not ideal for every prostate size or median-lobe anatomy.
Recovery after treatment
Burning, urgency, frequency, pelvic aching and blood in the urine can occur for several days to a few weeks. Most men return to light routine activity quickly, although strenuous exercise and cycling are usually avoided until bleeding and discomfort settle.
Symptoms often improve early, but urinary irritation can temporarily obscure the benefit during the first days.
Erections and ejaculation
UroLift is specifically attractive when ejaculation matters. Erectile and ejaculatory function are usually maintained, and the risk of retrograde ejaculation is much lower than with conventional TURP or HoLEP. Preservation is not a guarantee because baseline age, diabetes, medicines and prior procedures also affect sexual function.
Risks and side effects
- Temporary burning, urgency, frequency or pelvic discomfort.
- Blood in the urine.
- Temporary urinary retention requiring a catheter.
- Urinary infection.
- Implant-related irritation, encrustation or need for removal in uncommon situations.
- Persistent obstruction or need for additional BPH treatment later.
When should you seek urgent medical care?
- Inability to pass urine with a painful, full lower abdomen.
- Fever, rigors or feeling acutely unwell.
- Heavy bleeding or clots that block urine flow.
- A catheter that stops draining while the bladder feels full.
- Severe or worsening pain.
What to bring for consultation
- Ultrasound report showing prostate volume and post-void residual urine.
- Uroflowmetry result if available.
- Urine routine/culture and serum creatinine.
- PSA report when it has been advised as part of your prostate assessment.
- A list of prostate medicines, blood thinners and other regular medicines.
- Records of previous retention, catheterisation or prostate/urethral procedures.
FAQs
Does UroLift preserve ejaculation?
Usually yes. Preserving antegrade ejaculation is one of its main advantages, although no procedure can guarantee this in every patient.
How long do the implants stay in?
UroLift implants are intended to remain permanently. They are not routinely removed after the urinary channel has opened.
Is UroLift as effective as TURP?
It improves symptoms and flow, but comparative evidence shows TURP generally produces greater de-obstruction. UroLift offers a faster recovery and better sexual-function preservation in exchange for less powerful improvement and more retreatment.
Can UroLift be done for a median lobe?
Techniques and device indications have evolved, but guideline recommendations differ. Anatomy should be reviewed carefully; some patients with a prominent obstructing middle lobe are better served by another treatment.
Can I have TURP or HoLEP later if UroLift fails?
Yes, further prostate surgery is possible. The urologist should know the number and position of prior implants when planning subsequent treatment.
Related reading
- Enlarged Prostate: Symptoms, Causes and Treatment
- Rezūm vs UroLift: Which Is Better?
- UroLift vs TURP: Benefits, Limitations and Recovery
- Which Prostate Treatments Can Preserve Ejaculation?
- Uroflowmetry Test: What Your Urine Flow Rate Means
- Post-Void Residual Urine: How Much Urine Left in the Bladder Is Normal?
- Is Prostate Enlargement Cancer? BPH vs Prostate Cancer Explained
- Minimally Invasive Treatments for Enlarged Prostate
- Urologist in Latur
References
- European Association of Urology. EAU Guidelines on the Management of Non-neurogenic Male LUTS: Disease Management, 2026 https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts/chapter/disease-management
- American Urological Association. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia Guideline https://www.auanet.org/guidelines-and-quality/guidelines/bph-guideline
- National Institute for Health and Care Excellence. UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (HTG578) https://www.nice.org.uk/guidance/htg578
- British Association of Urological Surgeons. Prostate procedures: patient information https://www.baus.org.uk/patients/information_leaflets/category/8/prostate_procedures